SMTL ID : 6eoy.1

Transthyretin in complex with 4-(1,3-Benzothiazol-2-yl)-2-methylaniline

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.38 Å

Oligo State

homo-tetramer

Ligands

4 x BM8: 4-(1,3-benzothiazol-2-yl)-2-methyl-aniline(Non-covalent)

BM8.1: 11 residues within 4Å: Chain A: K.6, L.8, A.99, L.101, S.108 Chain C: K.6, L.8, A.99, L.101, S.108 Ligands: BM8.3 5 PLIP interactions: 2 interactions with chain A, 3 interactions with chain C Hydrophobic interactions: A:K.6, A:A.99, C:K.6, C:A.99, C:L.101 BM8.2: 13 residues within 4Å: Chain B: K.6, L.8, A.99, L.101, S.108 Chain D: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: BM8.4 6 PLIP interactions: 4 interactions with chain D, 2 interactions with chain B Hydrophobic interactions: D:K.6, D:A.99, B:K.6, B:L.101 Hydrogen bonds: D:S.108, D:S.108 BM8.3: 11 residues within 4Å: Chain A: K.6, L.8, A.99, L.101, S.108 Chain C: K.6, L.8, A.99, L.101, S.108 Ligands: BM8.1 5 PLIP interactions: 3 interactions with chain A, 2 interactions with chain C Hydrophobic interactions: A:K.6, A:A.99, A:L.101, C:K.6, C:A.99 BM8.4: 13 residues within 4Å: Chain B: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain D: K.6, L.8, A.99, L.101, S.108 Ligands: BM8.2 6 PLIP interactions: 2 interactions with chain D, 4 interactions with chain B Hydrophobic interactions: D:K.6, D:L.101, B:K.6, B:A.99 Hydrogen bonds: B:S.108, B:S.108

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cotrina, E.Y. et al., Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease. Eur.J.Med.Chem. (2021)

Release Date

2021-10-06

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence